Since the last reverse split, only about two years ago, investors' holdings have been devalued I believe by approx 95% - with the 'actual' pre-split price of those shares today equaling about 1.5 cents (pre-split price back then i believe was about .32 cents). Gives the sense that a few years back this was morphed into more of a trade manipulation and shorting vehicle for short-term gain by some. Now I guess the real question is will this be just another 'wash, rinse and repeat' with the second r/s; so if a similar trading pattern and devaluation occurs yet again, the shares will come out equaling what - some fraction of a penny? Hard to watch, but quite a lesson for any newbie or would-be investor to watch and learn.
Look, smart guy, it's only that Chip and Mike for all their years of 'backlog talk' have made a habit of missing quarterly estimates by wide margins on both the bottom and top lines - that's all. Apart from that rather small detail - and the fact that revenues now seem to be going in the wrong direction - I guess you can say that there is some good news to be found 'somewhere else' in the report. That's just great, smart guy. That's kinda like saying that although a MLB team keeps losing more and more games and are in a worsening slump, season after season, that at least they've made a habit of losing with more men on base - well that just great, super.
(that is 'what happened' to the supposed strong moat ... or is it that Nuan is quietly collecting royalties from the aforementioned companies? Thks
I thought it was always said that Nuance, the industry leader in voice recognition, had this vast patent estate in VR and a strong 'moat' surounding it. So why then does it seem all these major companies (Goog, Msft, Amazon, etc.) are able to come in and develop ambitious voice products and operate almost unencumbered in the space? Where is Nuance in this and happened to that strong moat?
Look, the company was only founded in 1969 -- give it some time to show that it can one day reach profitability. There is always future backlog, even though that may just confuse things even more as revenues seem only to keep declining as a result.
Unfortunately that 'is' the only thing that matters. Doesn't seem that Chip and Mike, for all their long-winded talks about rosy outlooks, exciting RFPs and backlog build-up are just not capable of reversing this glaring reality and right the ship ... and after so many years.
Still have a hard time figuring out if there are positive developments expected from the interim and they are expected this quarter then why not wait til then to secure a more favorable deal and price? Seems like a no brainer if you have any interest in maximizing the value of your assets as well as any sense of fiduciary duty to your shareholders (which I presumed is something not merely notional but obligatory).
Aren't these expected soon? Seems with that they could have negotiated for a higher price - and a better deal for both the company and shareholders. Doesn't make sense, if you consider at all basic fiduciary standards and responsiliblity towards shareholders.
I'm not great at math but I guess that means that the .26 now actually equates to less than .02 cents pps -- pre-split price of two years ago? And another reverse split that management may want to effect already, performing let's say under the same scenario, would bring the original pps down further still, to some decimal of .01 cents? Is that right? geez
(anyway, you probably already know that and are likely just hoping to short the stock again in the event of another r/s ... the old trick)
they just did a reverse split only 1-2 years ago. even though the pps has tumbled back all the way down, don't believe they will be allowed to enact another r/s so soon
I think for them it will end badly
Not disageeing with you Akon, just sayin' that after all these years, all the effort and investment, all the epochs and near misses, shifting managements and company sagas, would be nice if at long last DCTH finally achieved something, contributed something
- otherwise hard to explain the seeming uncanny and dedicated interest in spinning the same narrative now on almost a daily basis. So I guess that is how the game works until it is exposed.
Sure. My only point is if management were genuine about its intention to move forward with OM ph3 seems they would've taken the necessary steps to launch much sooner than now - in the 3+ years its taken them just to identify the treatment centers. Doesn't stand to reason - especially when the timing coincides with working capital running down.
(In other words, hard for me to imagine management as being serious about starting OM3 after delaying all this time, these 3 years, while in the process drawing down the little capital they had)
It's hard not to believe that if management were serious about launching OM ph3 then they would've done so long before now - and wouldn't have waited three years and counting to do so, when their cash box was flashing red. Really, one year, more or less, should've been enough time for them to get their ducks in a row with the FDA protocols and get OM3 up and running ... when they still had capital in the bank ... but that's if, as I said, they were serious about moving forward.
Would is be Nuance?
FDA SPA for P3 OM is a big deal ... but how long will it take the company to go back before the FDA and present trial results? I think the answer should've been by end 2016, if company was serious and had its ducks in a row ... but not starting OM 3 til now? Hard to imagine the decision-making/seriousness behind this ... not like it's sitting on a big cash war chest in an overseas account somewhere